The cannabinoid field is currently an active research area. Anandamide (AEA) and 2-
arachidonoylglycerol (2-AG) are the most characterized endogenous cannabinoids (also …

Since the discovery of endocannabinoids and their receptors, two major members of the
endocannabinoid family, anandamide (AEA) and 2-arachidonoylglycerol (2-AG), have been …

Cannabinoid receptors, the primary molecular targets of the endocannabinoid system, are
activated by specific bioactive lipids termed 'endocannabinoids'. These lipid transmitters are …

The major endocannabinoids, anandamide (N-arachidonoylethanolamide, 20: 4n− 6 N-
acylethanolamine) and 2-arachidonoylglycerol (2-AG) are structurally and functionally …

Endocannabinoids are a new class of lipid mediators, which includes amides and esters of
long-chain polyunsaturated fatty acids. Anandamide (I) and 2-arachidonoylglycerol (II) are …

The objective of this review is to point out some important facts that we don't know about
endogenous cannabinoids—lipid-derived signaling molecules that activate CB 1 …

Anandamide (AEA) and 2-arachidonyl glycerol (2-AG), endogenous ligands for the CB1 and
CB2 cannabinoid receptors, are referred to as endocannabinoids because they mimic the …

The biological activity of endocannabinoids like anandamide (AEA) and 2-
arachidonoylglycerol (2-AG) is subjected in vivo to a “metabolic control”, exerted mainly by …

Endocannabinoids were defined in 1995 as endogenous agonists of cannabinoid receptors,
ie of the G protein-coupled receptors for cannabis's psychoactive principle, Δ 9 …

The endocannabinoids are lipid-derived messengers that play a diversity of regulatory roles
in mammalian physiology. Dysfunctions in their activity have been implicated in various …